Literature DB >> 2785999

Transforming growth factor beta 1 (TGF-beta 1) receptor expression on resting and mitogen-activated T cells.

L Ellingsworth1, D Nakayama, J Dasch, P Segarini, P Carrillo, W Waegell.   

Abstract

Transforming growth factor beta 1 (TGF-beta 1) is a potent autocrine growth inhibitor of lymphocytes. In this study, the expression of TGF-beta 1 binding proteins was characterized on murine splenic T cells. With an affinity cross-linking method and by neutralizing antibodies to TGF-beta 1, [125I] TGF-beta 1 was found to bind to three cell surface-binding proteins (280-200 kD, 95-85 kD, 65 kD) that were differentially expressed on resting and mitogen-stimulated T cells. Freshly prepared (resting) T cells were found to constitutively express the 95-85-kD form of these binding proteins, whereas mitogenic stimulation by either concanavalin-A (Con-A), interleukin-1 (IL-1), interleukin-2 (IL-2), or 12-tetradecanoyl-phorbol-13-acetate (TPA) for 12-72 h induced the appearance of all forms of the TGF-beta 1 binding proteins (280-200 kD, 95-85 kD, and 65 kD). Furthermore, antibodies that neutralized the biologic action of TGF-beta 1 also blocked the binding of [125I] TGF-beta 1 to all three binding proteins, suggesting that these binding proteins are involved with signal transduction. These results suggest that the expression of the TGF-beta 1 receptor on T cells is regulated by T cell mitogenic signals and that a regulatory relationship may exist between T cell growth-promoting cytokines (IL-1 and IL-2) and the T cell growth inhibitor, TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785999     DOI: 10.1002/jcb.240390414

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production.

Authors:  B Brooks; K Chapman; J Lawry; A Meager; R C Rees
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Transforming growth factor-β receptors.

Authors:  P R Segarini
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

3.  Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.

Authors:  R J Capocasale; R J Lamb; E C Vonderheid; F E Fox; A H Rook; P C Nowell; J S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

4.  TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.

Authors:  Anne Dropmann; Tatjana Dediulia; Katja Breitkopf-Heinlein; Hanna Korhonen; Michel Janicot; Susanne N Weber; Maria Thomas; Albrecht Piiper; Esther Bertran; Isabel Fabregat; Kerstin Abshagen; Jochen Hess; Peter Angel; Cédric Coulouarn; Steven Dooley; Nadja M Meindl-Beinker
Journal:  Oncotarget       Date:  2016-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.